Skip to main
THC

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 39%
Buy 56%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare is well-positioned for growth due to its strategic investments in the higher-margin United Surgical Partners International (USPI) segment, which is expected to enhance the company’s return on invested capital (ROIC) and overall income from equity earnings. The organization is experiencing elevated demand and improved payer mix, coupled with state supplemental payments and reduced labor pressures, creating favorable conditions for margin expansion. Additionally, Tenet's focus on outpatient growth opportunities and a competitive cost structure positions it to benefit from increased visibility into future earnings performance.

Bears say

Tenet Healthcare's stock faces a negative outlook due to significant potential headwinds, including a $220 million impact from subsidy expirations in its Acute segment, which is projected to adversely affect its 2026 forecast. The organization's dependence on non-recurring funds, such as the $148 million from Medicaid in 2025, raises concerns about future revenue stability, further compounded by the expectation that 80-85% of affected individuals may become uninsured. Additionally, a projected 20% decline in Health Insurance Exchange (HIX) coverage could lead to decreased utilization rates, which would likely pressure Tenet's financial performance moving forward.

Tenet Healthcare (THC) has been analyzed by 18 analysts, with a consensus rating of Buy. 39% of analysts recommend a Strong Buy, 56% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 18 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Apr 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $243.28, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $243.28, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.